Cannabis Impairs Driving for Over Five Hours—Far Longer Than Users Believe
A recent study on cannabis driving impairment duration found that impairment lasts over five hours after use. Despite this, many users believe they are fit to drive sooner. Blood THC levels did not reliably predict driving performance in the study.
Endocannabinoid System & Child Autism Risk: New Evidence
Clinical studies reveal peripregnancy cannabis exposure autism risk linked to behavioral and developmental differences in children. Effects vary depending on the presence of ASD symptoms. This research highlights the importance of counseling on cannabis…
Cannabinoid Clinical Trials: CBD for Autism in Children
The CBD autism clinical trial study investigated oral CBD oil effects on autistic children aged 5 to 12 over 12 weeks. Results showed potential benefits for social relating, anxiety, and parental stress. This controlled trial provides early clinical…
Progression of Cannabis-Induced Psychosis to Schizophrenia and Bipolar Disorder
Cannabis induced psychosis schizophrenia bipolar progression is a critical clinical concern. Many patients with cannabis-induced psychosis later develop schizophrenia spectrum or bipolar disorder. Early identification and monitoring of this progression…
Endocannabinoid System: Cannabis Role in HIV Smoking Cessation
The endocannabinoid system cannabis hiv smoking cessation research highlights digital therapeutics tailored for people living with HIV. These tools show strong feasibility and acceptability as smoking cessation aids. This pilot trial suggests…
Cannabinoid Sodium Channel Research: Clinical Evidence Review
Cannabinoid sodium channel modulation offers a promising mechanism for pain relief by reducing activity in voltage-gated sodium channels. This modulation occurs independently of traditional cannabinoid receptors, suggesting alternative pathways for…
Endocannabinoid System & Autism Risk in Pregnancy Study
Children born to mothers who used cannabis during pregnancy showed a small but measurable increase in autism risk pregnancy cannabis studies. Cannabis compounds cross the placenta and interact with cannabinoid receptors in the fetal brain. Current…
Cannabinoids for Autism: Clinical Evidence & ECS Research
Cannabinoids for autism clinical evidence shows early promise in reducing irritability and hyperactivity in autism spectrum disorder. Current studies are limited but suggest potential benefits. More research is needed to confirm efficacy and safety.
Research on Anxiety, Depression, and Cannabis Use in Adolescents
Anxiety depression cannabis use adolescents is a critical area of study revealing that internalizing symptoms can increase cannabis use risk. Adolescents with depression or anxiety are more likely to initiate cannabis use as a coping mechanism. This…
Pre-Trauma Insomnia and Cannabis Use: Research Insights from AURORA
Pre trauma insomnia cannabis use research highlights the risk of substance use following trauma. Insomnia symptoms before trauma may predict cannabis and alcohol misuse. Early screening for sleep disturbances can guide interventions.
